| Product NDC: | 62856-832 |
| Proprietary Name: | Aricept |
| Non Proprietary Name: | donepezil hydrochloride |
| Active Ingredient(s): | 10 mg/1 & nbsp; donepezil hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 62856-832 |
| Labeler Name: | Eisai Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021720 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20041018 |
| Package NDC: | 62856-832-30 |
| Package Description: | 3 BLISTER PACK in 1 CARTON (62856-832-30) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| NDC Code | 62856-832-30 |
| Proprietary Name | Aricept |
| Package Description | 3 BLISTER PACK in 1 CARTON (62856-832-30) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Product NDC | 62856-832 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | donepezil hydrochloride |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20041018 |
| Marketing Category Name | NDA |
| Labeler Name | Eisai Inc. |
| Substance Name | DONEPEZIL HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |